Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Giant cell (temporal) arteritis: an overview and update.

Waheeda Rahman1, Farooq Z Rahman

  • 1Department of Ophthalmology, Leicester, United Kingdom.

Survey of Ophthalmology
|September 6, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infographic: Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, Phase 3 trial.

Eye (London, England)·2026
Same author

Infographic: FAME (fluocinolone acetonide for macular edema) trials of ILUVIEN® vitreous sustained-delivery inserts for diabetic macular oedema.

Eye (London, England)·2026
Same author

Infographic: FAME (fluocinolone acetonide for macular edema) trials of ILUVIEN® vitreous sustained-delivery inserts for diabetic macular oedema.

Eye (London, England)·2025
Same author

Significant improvement in structural and functional glaucoma damage in an adult patient following large, rapid medical reduction of pressure.

Eye (London, England)·2024
Same author

Two-year real-world outcome data from a single tertiary centre shows reduced ustekinumab persistence in a non-bio-naïve Crohn's disease cohort with penetrating disease, -ostomies and sarcopenia.

Therapeutic advances in chronic disease·2023
Same author

Randomized clinical trial: Long-term Staphylococcus aureus decolonization in patients on home parenteral nutrition.

Clinical nutrition (Edinburgh, Scotland)·2023

Giant cell arteritis is a serious condition that can cause vision loss. Prompt diagnosis and treatment, often with corticosteroids, are crucial for preventing permanent ophthalmic damage.

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Systemic Vasculitis

Background:

  • Giant cell arteritis (GCA) is a systemic vasculitis with significant ophthalmic implications.
  • Early diagnosis and treatment are critical to prevent irreversible vision loss.
  • The precise etiology of GCA remains elusive despite advances in understanding its pathogenesis.

Purpose of the Study:

  • To highlight the importance of prompt recognition and treatment of GCA.
  • To discuss diagnostic modalities and current therapeutic strategies for GCA.
  • To emphasize the role of ophthalmologists in the early management of GCA.

Main Methods:

  • Review of current literature on GCA pathogenesis, diagnosis, and treatment.
  • Discussion of clinical presentation, emphasizing visual manifestations.

Related Experiment Videos

  • Analysis of diagnostic tools including temporal artery biopsy, laboratory investigations, and fundus fluorescein angiography.

    • Main Results:

    • Visual disturbances are common presenting symptoms of GCA.
    • Temporal artery biopsy is the gold standard for diagnosis, but other methods aid in diagnosis.
    • Corticosteroids are the primary treatment, with immunosuppressants used as steroid-sparing agents in resistant cases.

    Conclusions:

    • High clinical suspicion is essential for timely intervention in GCA.
    • Effective management can minimize the risk of visual impairment.
    • Increased awareness of GCA can reduce the incidence of irreversible visual loss.